NCT01547234 Observational Study for Assessment of the Effect of Fampyra on the Manual Function of Persons With Multiple Sclerosis Status COMPLETED Phase N/A
NCT01539395 A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis Status WITHDRAWN Phase N/A
NCT01538225 Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity Status COMPLETED Phase PHASE3
NCT01535664 An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS) Status COMPLETED Phase N/A
NCT01517282 Phase Ib Study to Evaluate MOR103 in Multiple Sclerosis Status COMPLETED Phase PHASE1/PHASE2
NCT01516554 Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients Status TERMINATED Phase PHASE2
NCT01514370 Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a Status COMPLETED Phase PHASE2
NCT01512329 Pacing Activity Self-management for Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT01500408 Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01497262 Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01491100 Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis Status COMPLETED Phase N/A
NCT01487096 Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses Status COMPLETED Phase PHASE2
NCT01480076 Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis Status COMPLETED Phase PHASE4